169321 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
Sub-classes:METHOD FOR PREDICTING RESPONSE TO A CANCER TREATMENT
#2COMBINATION DRUG
#3Methods for Diagnosing and Treating Vestibular Schwannoma
#4PROTEIN BIOMARKERS FOR USE IN LUPUS NEPHRITIS
#5THERAPEUTIC AGENT FOR CORONAVIRUS INFECTION
#6Methods for Evaluating Angiogenesis
#7TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS
#8TACI ANTIBODY AND USE THEREOF
#9IN VITRO CELL-BASED POTENCY ASSAY
#10Methods and Treatment Involving Excess Free LIGHT
#11Improved monocyte activation test
#12PREVENTION AND TREATMENT OF CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY ASSOCIATED WITH CAR-T CELL THERAPY
#13PEPTIDES WITH CYTOKINE-RELEASING ACTIVITY AND METHODS FOR CHARACTERIZING CYTOKINE-RELEASING PROFILES OF PEPTIDES
#14ANTI-CCR8 ANTIBODIES AND USES THEREOF
#15METHODS OF FORMING PATIENT-DERIVED 3D CELL CULTURES FOR TRACKING LIVE IMMUNE-TUMOR INTERACTIONS
#16METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#17COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANTI-PD-1 ANTIBODIES
#18ANTIBODY MONO-OR MULTI-SPECIFIC TO EPHRIN TYPE-A RECEPTOR 10, CHIMERIC ANTIGEN RECEPTOR T-CELL EXPRESSING THE SAME AND USES THEREOF
#19MICROBIAL METABOLITES ON INTESTINAL INFLAMMATION
#20Methods of Detecting and Preventing Atopic Allergic Diseases
#21TARGETING GDF15-GFRAL PATHWAY
#22METHODS RELATING TO DIAGNOSING STABILITY FOLLOWING RENAL TRANSPLANTATION
#23SIGNATURE OF TL1A (TNFSF15) SIGNALING PATHWAY
#24PEPTIDE COMPOSITION AND USES THEREOF
#25METHODS OF DIAGNOSING AND TREATING MULTIPLE SCLEROSIS BY DETECTING A BIOMARKER IN THE CEREBROSPINAL FLUID
#26ASSAY AND METHODS FOR DRUG DISCOVERY
#27Methods, Kits and Compositions for Assessing and Treating Interstitial Cystitis
#28SYSTEM AND METHODS FOR DIAGNOSING ACUTE INTERSTITIAL NEPHRITIS
#29METHOD FOR TESTING TERTIARY LYMPHOID TISSUE, AND KIT FOR TESTING TERTIARY LYMPHOID TISSUE
#30PULMONARY ARTERIAL HYPERTENSION PATIENT SELECTION METHOD AND BIOMARKER
#31Compositions and Methods for Modulating Cytokines
#32PHYSISORPTION OF ANTIBODIES ON FILMS
#33HUMAN UMBILICAL CORD BLOOD FOR USE IN ALLEVIATING FATIGUE
#34METHOD AND SYSTEM FOR BRAIN LIQUID BIOPSY AND BRAIN TREATMENT METHOD
#35METHODS FOR EVALUATION OF EXTRACELLULAR VESICLES
#36METHODS FOR PREDICTING TREATMENT RESPONSE IN PSORIASIS
#37COMPOSITIONS AND METHODS OF TREATING SEPSIS IN PATIENTS USING ANTI-LIGHT ANTIBODIES
#38METHODS AND SYSTEMS OF PREDICTING MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C)
#39METHOD FOR CLASSIFYING CELLS
#40ANTIBODIES AGAINST CHEMOKINES, METHOD FOR IDENTIFYING SAID ANTIBODIES AND USES THEREOF
#41MARKER OF ALZHEIMER'S DISEASE AND USE THEREOF
#42TAG/ANTI-TAG SYSTEM FOR SIGNAL AMPLIFICATION IN IMMUNOASSAYS
#43METHOD FOR PREDICTING ATOPIC DERMATITIS RELAPSE
#44Atomic Description of Immune Complex that Causes Heparin-Induced Thrombocytopenia
#45METHODS OF ANALYZING SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 2 (STNFR2) AND USES THEREOF
#46ASSESSMENT OF PREECLAMPSIA USING ASSAYS FOR FREE AND DISSOCIATED PLACENTAL GROWTH FACTOR
#47BINDING-TRIGGERED TRANSCRIPTIONAL SWITCHES AND METHODS OF USE THEREOF
#48Coronavirus T Cell Epitopes, Megapools and Uses Thereof
#49MARKERS FOR PROGRESSION OF INFLAMMATORY LIVER DISEASE
#50METHOD FOR EVALUATING QUALITY OF INDUCEMENT INHIBITORY-T-CELL FORMULATION
#51METHODS OF USING AVERMECTIN COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS AND DOSING REGIMENS
#52METHOD OF ISOLATING AND ANALYZING CIRCULATING TUMOR CELLS
#53METHODS AND PRODUCTS FOR PREDICTING CANCER THERAPY-RELATED CARDIAC DYSFUNCTION
#54MULTI-FLUORESCENCE MICROFLUIDIC PLATFORM FOR EVALUATING RISKS OF SHEAR-DRIVEN ARTERIAL THROMBOSIS AND FAST ANTITHROMBOTIC DRUG SCREENING
#55HIGH RISK BIOMARKERS FOR MYELOMA PRECURSOR DISEASE PROGRESSION AND METHODS OF USE THEREOF
#56SIGNATURES AND DETERMINANTS FOR DIAGNOSING INFECTIONS AND METHODS OF USE THEREOF
#57NANOSENSORS AND USE THEREOF
#58MARKERS FOR THE EARLY DETECTION OF COLON CELL PROLIFERATIVE DISORDERS
#59HUMANIZED MOUSE MODELS FOR ASSESSING IMMUNE CELL THERAPY
#60CYTOKINE PROFILING ANALYSIS
#61METHODS OF DIAGNOSTIC SCREENING AND EARLY DETECTION OF ADENOMYOSIS
#62ARTIFICIAL INTELLIGENCE (AI) -BASED METHOD FOR IMMUNOGENICITY ASSESSMENT
#63METHOD FOR ASSESSING DIFFERENTIATION POTENTIAL OF CELLS IN CULTURE BROTH IN DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO NEURAL CELLS OF MIDBRAIN FLOOR PLATE REGION
#64ANTI-B7-H4 ANTIBODY, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#65METHODS FOR ENHANCED BCMA IMMUNOHISTOCHEMISTRY DETECTION IN HUMAN AND MONKEY TISSUE
#66MYELOPROLIFERATIVE CONDITIONS
#67BIOMARKERS FOR DIAGNOSING TUBERCULOUS MENINGITIS
#68ANTIBODIES AGAINST S100A8 AND S100A9, HETERODIMER OF S100A8 AND S100A9, DETECTION KIT AND USE OF THE ANTIBODIES, HETERODIMER AND DETECTION KIT
#69Methods for Sample Quality Assessment
#70IMMUNITY DETECTING KIT AND USING METHOD THEREOF
#71COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION
#72THERAPEUTIC BINDING MOLECULES
#73ANTIBODIES TO CANINE AND FELINE ONCOSTATIN M RECEPTOR BETA AND USES THEREOF
#74COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION
#75Methods for Sample Quality Assessment
#76METHOD FOR USING INFLAMMATORY MARKERS TO GUIDE ANTI-CLEVER-1 BASED CANCER TREATMENT
#77Apparatus and Methods For Monitoring Of Biomarkers In Blood
#78METHODS AND RELATED ASPECTS FOR DETECTING AND QUANTIFYING CHIMERIC ANTIGEN RECEPTOR T CELLS IN SAMPLES
#79METHODS AND DEVICES FOR STORING OR STABILIZING MOLECULES
#80METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#81Isolation and Diagnostics of Fetal Cells
#82IDENTIFICATION OF PATHOGENIC IMMUNE CELL SUBSETS IN CHECKPOINT INHIBITOR-INDUCED MYOCARDITIS
#83IN VITRO POINT-OF-CARE ASSAY METHOD/PROCESS USING COMBINATION OF BIOACTIVATED NON-MAGNETIC AND MAGNETIC QUANTUM DOTS FOR RAPID IMMUNO-OPTOMAGNETIC DETECTION OF SERUM BIOMARKERS IN FREE SOLUTION
#84RATIOS OF sFlt-1 TO P1GF OR ENDOGLIN TO P1GF AS BIOMARKERS FOR PREECLAMPSIA RELATED ADVERSE OUTCOMES AFTER BIRTH
#85MECHANISM OF ACTION
#86UNIVERSAL TIL CYTOTOXICITY ASSAY
#87METHOD FOR OPTIMIZING DRUG SELECTION
#88COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING PARKINSON'S DISEASE
#89METHODS OF DIAGNOSIS AND TREATMENT OF EPILEPSY BASED ON GASTROINTESTINAL MICROBIOTA ALTERATIONS
#90BIOMARKERS FOR DIAGNOSING TUBERCULOSIS
#91PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#92URINARY BIOMARKERS FOR ACTIVE LUPUS NEPHRITIS AND METHODS OF USE THEREOF
#93SMALL MOLECULE TRAIL GENE INDUCTION BY NORMAL AND TUMOR CELLS AS AN ANTICANCER THERAPY
#94USE OF BIOMARKERS IN DIAGNOSING AND TREATING LUPUS NEPHRITIS
#95POTENCY ASSAY
#96MINIMALLY-INVASIVE MEASUREMENT OF ESOPHAGEAL INFLAMMATION
#97ANTI-EPHA4 ANTIBODY
#98Prediction of Severity of COVID-19 and Methods of Treatment
#99EARLY DIAGNOSIS OF INFECTIONS
#100Anti-TSLP nanobodies and their applications
#101ANTI-CCR8 ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF, AND AGENTS AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME
#102METHOD FOR OBTAINING APRIL-BINDING PEPTIDES, PROCESS FOR PRODUCING THE PEPTIDES, APRIL-BINDING PEPTIDES OBTAINABLE WITH SAID METHOD/PROCESS AND USE OF THE APRIL-BINDING PEPTIDES
#103CCL20 PROMOTER-REGULATED GENE EXPRESSION
#104VAGUS NERVE STIMULATION PRE-SCREENING TEST
#105Nanomembrane Device And Method For Biomarker Sampling
#106COMPOSITION CONTAINING TARC, DILUENT, METHOD FOR REDUCING TARC CARRYOVER, ADSORPTION INHIBITOR, AND CONTINUOUS ANALYSIS METHOD
#107IGFR-LIKE 2 RECEPTOR AND USES THEREOF
#108ANTI-ERYTHROPOIETIN ANTIBODY
#109METHOD OF DETERMINING TOXICITY OF AN IMMUNOMODULATORY DRUG FOR USE IN HUMANS
#110BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME
#111METHOD FOR THE QUANTIFICATION OF THE ACTIVATION STATE OF G-PROTEIN-COUPLED RECEPTORS IN A HUMAN BIOLOGICAL SAMPLE
#112METHODS FOR ASSIGNING A PHENOTYPIC SIGNATURE FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
#113COMPOSITION FOR PREVENTING OR TREATING OF ISCHEMIC CEREBROVASCULAR DISEASE COMPRISING AN ARGINASE-1 INHIBITOR
#114Atomic description of immune complex that causes heparin-induced thrombocytopenia
#115GDF15 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#116COMPOSITIONS AND METHODS FOR DETECTING, PREVENTING, AND TREATING DISTURBED MICROBIOTA-IMMUNE HOMEOSTASIS
#117SEQUENCING MICROBIAL CELL-FREE NUCLEIC ACIDS TO DETECT INFLAMMATION, SECONDARY INFECTION, AND DISEASE SEVERITY
#118Methods of Predicting Atopic Dermatitis
#119Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
#120BIVALENT LIGANDS TO UNDERSTAND DIMERIZATION OF THE MU OPIOID RECEPTOR AND THE CHEMOKINE RECEPTOR CCR5 IN NEUROLOGICAL DISORDERS
#121Method of Tracking Maintenance of Immunological Tolerance
#122METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#123RAPID SCREENING METHODS FOR THYROID ASSOCIATED ORBITOPATHY
#124METHODS AND COMPOSITIONS FOR IPSC-DERIVED MICROGLIA
#125METHODS OF GRAFT VERSUS HOST DISEASE DIAGNOSIS
#126THERAPEUTIC BINDING MOLECULES
#127Method of Evaluating Efficacy of Chiropractic Care for Chronic Lower Back Patients
#128ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF
#129METHODS OF PREDICTING AND TREATING IMMUNOTHERAPY TOXICITY BASED ON IMMUNE CELL POPULATIONS
#130ANTIBODIES AGAINST TL1A AND USES THEREOF
#131RAPID PROCESSING AND DIRECT TESTING OF SALIVA BIOMARKERS
#132METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS
#133SEQUENCING MICROBIAL CELL-FREE NUCLEIC ACIDS TO DETECT INFLAMMATION, SECONDARY INFECTION, AND DISEASE SEVERITY
#134ANTIBODIES AND ASSAYS FOR CCL14
#135METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#136METHODS AND COMPOSITIONS RELATED TO TOXICITY ASSOCIATED WITH CELL THERAPY
#137LIQUID BIOPSY YIELD ENHANCEMENT
#138TNF ALPHA AND NGF ANTIBODIES FOR VETERINARY USE
#139ANTI-APRIL ANTIBODIES AND USES THEREOF
#140POTENCY ASSAY
#141BIOMARKERS COMPOSITION RELATED TO DIAGNOSIS AND PROGNOSIS OF IMMUNOGLOBULIN A NEPHROPATHY AND APPLICATION THEREOF
#142ENHANCED ANTI-HVEM ANTIBODIES AND USE THEREOF
#143COMPOSITIONS AND METHODS FOR SINGLE CELL ANALYTE DETECTION AND ANALYSIS
#144ANTI-C5 ANTIBODIES AND METHODS OF USE
#145Pharmaceuticals That Promote Functional Regeneration of Damaged Tissues
#146DNA APTAMERS FOR THE DETECTION OF MONOMERIC CRP
#147HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN-1ALPHA
#148TICK CHEMOKINE BINDING PROTEINS FOR USE IN THERAPY AND DIAGNOSIS
#149IMMUNOMODULATORY CLINICAL BIOMARKER PROFILES AND USES THEREOF
#150Device and method for detection of analytes
#151USES OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES IN COMBINATION WITH INHIBITORS OF INFLAMMATION-RELATED SOLUBLE FACTORS
#152METHODS AND TREATMENT INVOLVING EXCESS FREE LIGHT
#153Method of determining toxicity of an immunomodulatory drug for use in humans preliminary class
#154COMPOSITIONS AND METHODS INVOLVING ANTIBODY CONSTRUCTS
#155EGG, FERTILIZED EGG, OR EMBRYO QUALITY IMPROVING AGENT
#156PRODUCTS AND METHODS FOR THE DIAGNOSIS AND DIFFERENTIATION OF HEPARIN-INDUCED THROMBOCYTOPENIA FROM VACCINE-INDUCED IMMUNE THROMBOTIC THROMBOCYTOPENIA AND NON-HEPARIN-INDUCED THROMBOCYTOPENIA
#157INHIBITION OF CASPASE PATHWAY AS A TREATMENT FOR LYSOSOMAL STORAGE DISORDERS
#158COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING MICROPARTICLE-ASSOCIATED DISEASES AND CONDITIONS
#159A COMPOSITION COMPRISING MESENCHYMAL PRECURSOR OR STEM CELLS AND THEIR USE
#160METHOD FOR DETERMINING THE FREE ANTIGEN OF AN ANTIBODY IN A SAMPLE
#161Biomarkers for neurogenerative disease
#162ANTIBODY ANTI IL17
#163COMPOSITIONS AND METHODS FOR PERSONALIZED TREATMENT OF NEURODEGENERATIVE CONDITIONS OR SIDE EFFECTS THEREOF
#164CYTOKINE BASED ASSESSMENT OF RECIPIENT ABILITY TO RESPOND TO STEM CELL THERAPY FOR CARTILAGE REGENERATION
#165METHODS FOR ISOLATING CENTRAL NERVOUS SYSTEM SURFACE MARKER DISPLAYING AGENTS
#166METHOD OF USING EXTRACELLULAR VESICLES TO DETECT COMPLEMENT ACTIVATION, AND USES THEREOF TO ASSESS AND/OR MONITOR TREATMENT OF A COMPLEMENT-MEDIATED DISEASE
#167MULTIPLE MEDIATORS TARGETED MULTIFUNCTIONAL NANOPARTICLES AND USES THEREOF
#168Biomarkers in Primary Biliary Cholangitis
#169PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY
#170OPTIMIZED METHOD FOR DECONTAMINATING PRODUCTION OF GLUCOSE POLYMERS AND GLUCOSE POLYMER HYDROLYZATES
#171METHODS FOR PREDICTION, DETECTION AND MONITORING OF SUBSTANCEUSE DISORDERS AND/OR AN INFECTION
#172METHODS FOR QUANTIFYING POTENCY OF REGENERATIVE IMMUNOTHERAPIES
#173COMPOSITION CONTAINING TARC, AND METHOD FOR IMPROVING STORAGE STABILITY OF TARC
#174Biomarkers for Systemic Lupus Erythematosus Disease, and Intensity and Flare
#175COMPOSITION CONTAINING TARC, AND METHOD FOR IMPROVING STORAGE STABILITY OF TARC
#176ANTI-CD70 ANTIBODY AND APPLICATION THEREOF
#177METHOD AND SYSTEM FOR DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL DISEASES
#178FMT PERFORMANCE PREDICTION TEST TO GUIDE AND OPTIMIZE THERAPEUTIC MANAGEMENT OF GVHD PATIENTS
#179BIOMARKERS FOR VITILIGO
#180Detection and quantification of AKT-mTOR pathway proteins
#181COMPOSITIONS OF SMAD7 ANTISENSE OLIGONUCLEOTIDES (ASO) AND METHODS OF USING THE SAME
#182Antibodies binding TNFR2 and uses thereof
#183DETERMINATION OF FREE N-TERMINUS OF PEGFILGRASTIM USING AN ACID PROTEASE
#184Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#185MODULATOR ASSAY
#186Stem Cell Memory T Cells, Methods and Uses for Modulating Inflammatory Responses, and Diagnosing and Treating Adverse Cardiovascular Events and Disease
#187Use Of Biomarker Or Biomarkers Combinations In Preparing A Diagnostic Reagent For Fulminant Myocarditis And A Drug For Fulminant Myocarditis
#188INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS
#189High-affinity peptide for tumor necrosis factor alpha and application thereof
#190KIDNEY HEALTH MONITORING IN HYPERTENSION PATIENTS
#191METHODS OF ADMINISTERING ANTI-OX40 ANTIBODIES
#192Methods for Diagnosing and/or Predicting the Risk of Having an Acute Rejection (AR) in a Kidney Transplant Recipient
#193Atomic description of immune complex that causes heparin-induced thrombocytopenia
#194Flow Cytometry System and Methods for the Diagnosis of Infectious Disease
#195METHODS OF ADMINISTERING ANTI-OX40 ANTIBODIES
#196BIOMARKERS FOR DETECTING OF OUTCOME/RISK OF THE PATIENTS WITH A RESPIRATORY ILLNESS
#197Biomarker of gingivitis diagnosis and treatment
#198TOOLS AND METHODS FOR EXPRESSION OF MEMBRANE PROTEINS
#199METHODS OF MINIMIZING NEUROTOXICITY ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY
#200METHODS OF PROGNOSIS
#201METHODS RELATED TO TOXICITY AND RESPONSE ASSOCIATED WITH CELL THERAPY FOR TREATING B CELL MALIGNANCIES
#202ASSESSMENT OF PREECLAMPSIA USING ASSAYS FOR FREE AND DISSOCIATED PLACENTAL GROWTH FACTOR
#203ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF
#204METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#205METHOD FOR SCREENING THERAPEUTIC DRUG USED FOR TREATING PSORIASIS
#206Target peptides for immunotherapy and diagnostics
#207CHARACTERISTIC ANALYSIS METHOD AND CLASSIFICATION OF PHARMACEUTICAL COMPONENTS BY USING TRANSCRIPTOMES
#208Toxicity Management for Anti-Tumor Activity of CARs
#209PIF BINDING AS A MARKER FOR IMMUNE DYSREGULATION
#210CLINICAL MANAGEMENT OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
#211METHODS OF ANALYSIS OF BLOOD FROM DECEASED DONORS
#212METHOD FOR EVALUATING SAFETY OF SUBSTANCE IN VITRO USING HUMAN IMMORTALIZED MYELOID CELLS
#213NEW APPLICATION OF CHEMOKINE RECEPTOR CCR6 INHIBITOR IN PREVENTING RECURRENCE OF PSORIASIS
#214TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF
#215Pulmonary hypertension biomarker
#216METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#217STABILIZED C-FMS INTRACELLULAR FRAGMENTS (FICD) PROMOTE OSTEOCLAST DIFFERENTIATION AND ARTHRITIC BONE EROSION
#218Signature of TL1A (TNFSF15) signaling pathway
#219TREATMENT OF ARDS AND OTHER CONDITIONS CAUSED BY ACUTELY ELEVATED CYTOKINE LEVELS AND POST ARDS CHRONIC CYTOKINE PRODUCTION USING INHALED ANESTHETICS
#220ANTIBODIES AND ASSAYS FOR CCL14
#221AZETIDINYL-ACETAMIDES AS CXCR7 INHIBITORS
#222IN VITRO METHOD FOR OBTAINING CLINICAL DATA IN PATIENTS SUFFERING FROM AN INFLAMMATORY DISEASE
#223Methods of prognosis and treatment
#224METHODS OF RISK ASSESSMENT AND DISEASE CLASSIFICATION
#225S-LAYER PROTEIN 2D LATTICE COUPLED DETERGENT-FREE GPCR BIOELECTRONIC INTERFACES, DEVICES, AND METHODS FOR USE THEREOF
#226Antibodies targeting B-cell maturation antigen and methods of use
#227SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#228Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
#229BIOACTIVE PHYTOCHEMICALS
#230SPECTRALLY FILTERED PHOTODIODE PAIR
#231METHODS AND DEVICES FOR STORING OR STABILIZING MOLECULES
#232Inhibition of cytokine-induced SH2 protein in NK cells
#233SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#234METHOD
#235METHODS AND PRODUCTS FOR TREATMENT OF GASTROINTESTINAL DISORDERS
#236Biomarkers of fast progression of chronic kidney disease
#237Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#238METHODS FOR EVALUATION AND TREATMENT OF RENAL INJURY BASED ON C-C MOTIF CHEMOKINE LIGAND 14 MEASUREMENT
#239Therapeutically Triggering an Innate Immune Response in a Target Tissue
#240Early diagnosis of infections
#241Methods for Detecting A Mycobacterium Tuberculosis Infection
#242Humanized mouse models for assessing immune cell therapy
#243METHODS OF USING IL-21 FOR ADOPTIVE IMMUNOTHERAPY AND IDENTIFICATION OF TUMOR ANTIGENS
#244TREATMENT OF AUTOIMMUNE LIVER DISEASE
#245METHODS OF TREATING A TRAUMATIC BRAIN INJURY
#246Antibodies to canine and feline oncostatin M receptor beta and uses thereof
#247ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF
#248Cytokine profiling analysis
#249Kit comprising contiguous nucleobases, including position 76, of RS5745994
#250METHOD FOR PREDICTING PROANGIOGENIC POTENTIAL OF EXTRACELLULAR VESICLES (EVS)
#251Biomarkers of neutrophil deregulation as diagnostic for gingivitis
#252POLLUTION PROTECTION FACTOR OF COSMETIC COMPOSITIONS
#253CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS
#254IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY
#255USE OF A STIMULATING AGENT TO ASSAY IMMUNE CELL POTENCY
#256USE OF PLASMA MEMBRANE PARTICLES, LIPOSOMES, AND EXOSOMES TO ASSAY IMMUNE CELL POTENCY
#257Nanosensors and use thereof
#258BIOMARKERS AND TREATMENT OF NEURONAL INJURY AND NEURODEGENERATION
#259ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF
#260USE OF PERIPHERAL BLOOD PRO- AND ANTI-INFLAMMATORY CYTOKINE RATIOS AS MARKERS OF IMPLANTATION PRECEDING PREGNANCY
#261Compositions and Methods to Detect Non-Coeliac Gluten Sensitivity
#262Methods of use of anti-TNFα antibodies
#263Use of anti-FAM19A5 antibodies for treating fibrosis
#264SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#265SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#266SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#267SYSTEM AND METHOD FOR REMOVAL OF IMMUNE INHIBITORS FROM BIOLOGICAL FLUIDS
#268Signatures and determinants for diagnosing infections and methods of use thereof
#269Vagus nerve stimulation pre-screening test
#270Inhibition of cytokine-induced SH2 protein in NK cells
#271Inhibition of cytokine-induced SH2 protein in NK cells
#272Protein signatures for distinguishing between bacterial and viral infections
#273METHOD OF DETERMINING TOXICITY OF AN IMMUNOMODULATORY DRUG FOR USE IN HUMANS
#274METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS
#275TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF
#276Method for diagnosis and subtyping of adult onset Still's disease
#277Assessment of preeclampsia using assays for free and dissociated placental growth factor
#278PEPTIDE COMPOSITION AND USES THEREOF
#279ANTIBODIES AGAINST TL1A AND USES THEREOF
#280COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#281GFRAL EXTRACELLULAR DOMAINS AND METHODS OF USE
#282Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a sample
#283ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF
#284Method of treating acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) associate with COVID-19 by administering an anti-LIGHT antibody
#285METHOD FOR OBTAINING INFORMATION ON RISK OF REDUCED RESPIRATORY FUNCTION IN PATIENT WITH INTERSTITIAL PNEUMONIA
#286Antibodies to granulocyte-macrophage colony stimulating factor and uses thereof
#287Fusion proteins comprising an anti-CD40 antibody and cancer antigens
#288Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#289Anti-CXCL13 antibodies for treating autoimmune diseases and cancer
#290Immune Monitoring of Neuro-Inflammatory Amyotrophic Lateral Sclerosis (ALS)
#291PREDICTION AND TREATMENT OF IMMUNOTHERAPEUTIC TOXICITY
#292PREDICTION OF DRUG-FREE REMISSION IN RHEUMATOID ARTHRITIS
#293METHOD FOR PREDICTING THERAPEUTIC EFFECT OF BIOLOGICAL PREPARATION ON RHEUMATOID ARTHRITIS
#294Methods of prognosis and treatment
#295FUSION PROTEINS COMPRISING AN ANTI-CD40 ANTIBODY AND HIV ANTIGENIC PEPTIDES
#296Method and means for diagnosing and treating allergy
#297CCL24 as a diagnostic and therapeutic target for breast cancer
#298Methods for Evaluating Angiogenesis
#299METHODS AND COMPOSITIONS RELATING TO PERSONALIZED PAIN MANAGEMENT
#300Biomarkers for diagnosing tuberculous meningitis